Psychedelic Drugs Market Size, Share, Growth, and Industry Analysis, By Types (Psilocybin, LSD, MDMA, DMT, Ketamine, Others), By Applications (Depressive Disorders, Post-Traumatic Stress Disorders, Substance Abuse Disorders, Obsessive Compulsive Disorders, Others) , and Regional Insights and Forecast to 2035

Detailed TOC of Global Psychedelic Drugs Industry Trends Analysis Report 2026, Forecast to 2035 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Psychedelic Drugs Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Psychedelic Drugs Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Psychedelic Drugs Business Mode and Production Process
2.3.1 Psychedelic Drugs Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Psychedelic Drugs Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Psychedelic Drugs
2.4.2 Raw Material Cost of Psychedelic Drugs
2.4.3 Labor Cost of Psychedelic Drugs
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Psychedelic Drugs Revenue and Market Share by Manufacturer (2020-2026)
4.2 Global Psychedelic Drugs Sales Volume and Market Share by Manufacturer (2020-2026)
4.3 Global Psychedelic Drugs Price by Manufacturer (2020-2026)
4.4 Psychedelic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Psychedelic Drugs, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Psychedelic Drugs, Product Offered and Application
4.7 Psychedelic Drugs Market Competitive Situation and Trends
4.7.1 Psychedelic Drugs Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Psychedelic Drugs Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Psychedelic Drugs Market Historical Development by Geographic Region (2020-2026)
5.1 Global Psychedelic Drugs Market Historical Sales Volume by Geographic Region (2020-2026)
5.2 Global Psychedelic Drugs Market Historical Revenue by Geographic Region (2020-2026)
5.3 North America Psychedelic Drugs Market Status by Country (2020-2026)
5.3.1 North America Psychedelic Drugs Sales Volume by Country (2020-2026)
5.3.2 North America Psychedelic Drugs Revenue by Country (2020-2026)
5.3.3 United States Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.3.4 Canada Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.4 Europe Psychedelic Drugs Market Status by Country (2020-2026)
5.4.1 Europe Psychedelic Drugs Sales Volume by Country (2020-2026)
5.4.2 Europe Psychedelic Drugs Revenue by Country (2020-2026)
5.4.3 Germany Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.4.4 France Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.4.5 United Kingdom Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.4.6 Spain Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.4.7 Russia Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.4.8 Poland Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.5 Asia Pacific Psychedelic Drugs Market Status by Country (2020-2026)
5.5.1 Asia Pacific Psychedelic Drugs Sales Volume by Country (2020-2026)
5.5.2 Asia Pacific Psychedelic Drugs Revenue by Country (2020-2026)
5.5.3 China Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.5.4 Japan Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.5.5 South Korea Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.5.6 Southeast Asia Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.5.7 India Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.5.8 Australia Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.6 Latin America Psychedelic Drugs Market Status by Country (2020-2026)
5.6.1 Latin America Psychedelic Drugs Sales Volume by Country (2020-2026)
5.6.2 Latin America Psychedelic Drugs Revenue by Country (2020-2026)
5.6.3 Mexico Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.6.4 Brazil Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.7 Middle East and Africa Psychedelic Drugs Market Status by Country (2020-2026)
5.7.1 Middle East and Africa Psychedelic Drugs Sales Volume by Country (2020-2026)
5.7.2 Middle East and Africa Psychedelic Drugs Revenue by Country (2020-2026)
5.7.3 GCC Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)
5.7.4 South Africa Psychedelic Drugs Sales Volume, Revenue and Growth (2020-2026)

6 Global Psychedelic Drugs Market Historical Development by Product Type (2020-2026)
6.1 Psychedelic Drugs Definition by Type
6.2 Global Psychedelic Drugs Historical Sales Volume by Product Type (2020-2026)
6.3 Global Psychedelic Drugs Historical Revenue by Product Type (2020-2026)
6.4 Global Psychedelic Drugs Historical Price by Product Type (2020-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2020-2026)
6.5.1 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of Psilocybin (2020-2026)
6.5.2 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of LSD (2020-2026)
6.5.3 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of MDMA (2020-2026)
6.5.4 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of DMT (2020-2026)
6.5.5 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of Ketamine (2020-2026)
6.5.6 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of Others (2020-2026)

7 Global Psychedelic Drugs Market Historical Development by End User (2020-2026)
7.1 Downstream Market Overview
7.2 Global Psychedelic Drugs Historical Sales Volume by End User (2020-2026)
7.3 Global Psychedelic Drugs Historical Revenue by End User (2020-2026)
7.4 Global Psychedelic Drugs Historical Price by End User (2020-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2020-2026)
7.5.1 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of Depressive Disorders (2020-2026)
7.5.2 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of Post-Traumatic Stress Disorders (2020-2026)
7.5.3 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of Substance Abuse Disorders (2020-2026)
7.5.4 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of Obsessive Compulsive Disorders (2020-2026)
7.5.5 Global Psychedelic Drugs Historical Sales Volume, Revenue and Growth Rate of Others (2020-2026)

8 Leading Companies Profiles
8.1 Eli Lilly
8.1.1 Eli Lilly Corporation Information
8.1.2 Eli Lilly - Psychedelic Drugs Product Portfolio and Specification
8.1.3 Eli Lilly Performance Analysis (2020-2026)
8.1.4 Eli Lilly Business and Markets Served
8.1.5 Eli Lilly Recent Developments
8.2 Seelos Therapeutics
8.2.1 Seelos Therapeutics Corporation Information
8.2.2 Seelos Therapeutics - Psychedelic Drugs Product Portfolio and Specification
8.2.3 Seelos Therapeutics Performance Analysis (2020-2026)
8.2.4 Seelos Therapeutics Business and Markets Served
8.2.5 Seelos Therapeutics Recent Developments
8.3 ATAI Life Sciences
8.3.1 ATAI Life Sciences Corporation Information
8.3.2 ATAI Life Sciences - Psychedelic Drugs Product Portfolio and Specification
8.3.3 ATAI Life Sciences Performance Analysis (2020-2026)
8.3.4 ATAI Life Sciences Business and Markets Served
8.3.5 ATAI Life Sciences Recent Developments
8.4 Cybin Inc
8.4.1 Cybin Inc Corporation Information
8.4.2 Cybin Inc - Psychedelic Drugs Product Portfolio and Specification
8.4.3 Cybin Inc Performance Analysis (2020-2026)
8.4.4 Cybin Inc Business and Markets Served
8.4.5 Cybin Inc Recent Developments
8.5 NUMINUS WELLNESS
8.5.1 NUMINUS WELLNESS Corporation Information
8.5.2 NUMINUS WELLNESS - Psychedelic Drugs Product Portfolio and Specification
8.5.3 NUMINUS WELLNESS Performance Analysis (2020-2026)
8.5.4 NUMINUS WELLNESS Business and Markets Served
8.5.5 NUMINUS WELLNESS Recent Developments
8.6 Entheon Biomedical
8.6.1 Entheon Biomedical Corporation Information
8.6.2 Entheon Biomedical - Psychedelic Drugs Product Portfolio and Specification
8.6.3 Entheon Biomedical Performance Analysis (2020-2026)
8.6.4 Entheon Biomedical Business and Markets Served
8.6.5 Entheon Biomedical Recent Developments
8.7 Pfizer
8.7.1 Pfizer Corporation Information
8.7.2 Pfizer - Psychedelic Drugs Product Portfolio and Specification
8.7.3 Pfizer Performance Analysis (2020-2026)
8.7.4 Pfizer Business and Markets Served
8.7.5 Pfizer Recent Developments
8.8 Intellipharmaceutics
8.8.1 Intellipharmaceutics Corporation Information
8.8.2 Intellipharmaceutics - Psychedelic Drugs Product Portfolio and Specification
8.8.3 Intellipharmaceutics Performance Analysis (2020-2026)
8.8.4 Intellipharmaceutics Business and Markets Served
8.8.5 Intellipharmaceutics Recent Developments
8.9 Red Light Holland
8.9.1 Red Light Holland Corporation Information
8.9.2 Red Light Holland - Psychedelic Drugs Product Portfolio and Specification
8.9.3 Red Light Holland Performance Analysis (2020-2026)
8.9.4 Red Light Holland Business and Markets Served
8.9.5 Red Light Holland Recent Developments
8.10 Revive Therapeutics
8.10.1 Revive Therapeutics Corporation Information
8.10.2 Revive Therapeutics - Psychedelic Drugs Product Portfolio and Specification
8.10.3 Revive Therapeutics Performance Analysis (2020-2026)
8.10.4 Revive Therapeutics Business and Markets Served
8.10.5 Revive Therapeutics Recent Developments
8.11 Mydecine Innovations Group
8.11.1 Mydecine Innovations Group Corporation Information
8.11.2 Mydecine Innovations Group - Psychedelic Drugs Product Portfolio and Specification
8.11.3 Mydecine Innovations Group Performance Analysis (2020-2026)
8.11.4 Mydecine Innovations Group Business and Markets Served
8.11.5 Mydecine Innovations Group Recent Developments
8.12 GlaxoSmithKline
8.12.1 GlaxoSmithKline Corporation Information
8.12.2 GlaxoSmithKline - Psychedelic Drugs Product Portfolio and Specification
8.12.3 GlaxoSmithKline Performance Analysis (2020-2026)
8.12.4 GlaxoSmithKline Business and Markets Served
8.12.5 GlaxoSmithKline Recent Developments
8.13 Acadia Pharmaceuticals
8.13.1 Acadia Pharmaceuticals Corporation Information
8.13.2 Acadia Pharmaceuticals - Psychedelic Drugs Product Portfolio and Specification
8.13.3 Acadia Pharmaceuticals Performance Analysis (2020-2026)
8.13.4 Acadia Pharmaceuticals Business and Markets Served
8.13.5 Acadia Pharmaceuticals Recent Developments
8.14 Braxia Scientific
8.14.1 Braxia Scientific Corporation Information
8.14.2 Braxia Scientific - Psychedelic Drugs Product Portfolio and Specification
8.14.3 Braxia Scientific Performance Analysis (2020-2026)
8.14.4 Braxia Scientific Business and Markets Served
8.14.5 Braxia Scientific Recent Developments
8.15 MindMed
8.15.1 MindMed Corporation Information
8.15.2 MindMed - Psychedelic Drugs Product Portfolio and Specification
8.15.3 MindMed Performance Analysis (2020-2026)
8.15.4 MindMed Business and Markets Served
8.15.5 MindMed Recent Developments
8.16 HAVN Life Sciences
8.16.1 HAVN Life Sciences Corporation Information
8.16.2 HAVN Life Sciences - Psychedelic Drugs Product Portfolio and Specification
8.16.3 HAVN Life Sciences Performance Analysis (2020-2026)
8.16.4 HAVN Life Sciences Business and Markets Served
8.16.5 HAVN Life Sciences Recent Developments
8.17 Field Trip Health
8.17.1 Field Trip Health Corporation Information
8.17.2 Field Trip Health - Psychedelic Drugs Product Portfolio and Specification
8.17.3 Field Trip Health Performance Analysis (2020-2026)
8.17.4 Field Trip Health Business and Markets Served
8.17.5 Field Trip Health Recent Developments
8.18 Mind Cure Health
8.18.1 Mind Cure Health Corporation Information
8.18.2 Mind Cure Health - Psychedelic Drugs Product Portfolio and Specification
8.18.3 Mind Cure Health Performance Analysis (2020-2026)
8.18.4 Mind Cure Health Business and Markets Served
8.18.5 Mind Cure Health Recent Developments
8.19 Jannsen
8.19.1 Jannsen Corporation Information
8.19.2 Jannsen - Psychedelic Drugs Product Portfolio and Specification
8.19.3 Jannsen Performance Analysis (2020-2026)
8.19.4 Jannsen Business and Markets Served
8.19.5 Jannsen Recent Developments
8.20 COMPASS Pathways PLC
8.20.1 COMPASS Pathways PLC Corporation Information
8.20.2 COMPASS Pathways PLC - Psychedelic Drugs Product Portfolio and Specification
8.20.3 COMPASS Pathways PLC Performance Analysis (2020-2026)
8.20.4 COMPASS Pathways PLC Business and Markets Served
8.20.5 COMPASS Pathways PLC Recent Developments

9 Global Psychedelic Drugs Market Forecast by Product Type and End User (2026-2035)
9.1 Global Psychedelic Drugs Market Forecast by Product Type (2026-2035)
9.1.1 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of Psilocybin (2026-2035)
9.1.2 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of LSD (2026-2035)
9.1.3 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of MDMA (2026-2035)
9.1.4 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of DMT (2026-2035)
9.1.5 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of Ketamine (2026-2035)
9.1.6 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2035)
9.2 Global Psychedelic Drugs Market Forecast by End User (2026-2035)
9.2.1 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of Depressive Disorders (2026-2035)
9.2.2 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of Post-Traumatic Stress Disorders (2026-2035)
9.2.3 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of Substance Abuse Disorders (2026-2035)
9.2.4 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of Obsessive Compulsive Disorders (2026-2035)
9.2.5 Global Psychedelic Drugs Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2035)

10 Global Psychedelic Drugs Market Forecast by Geographic Region (2026-2035)
10.1 Global Psychedelic Drugs Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Psychedelic Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer